Paclitaxel-loaded biodegradable ROS-sensitive nanoparticles for cancer therapy

Abhilash D Pandya,1 Eliézer Jäger,2 Shahla Bagheri Fam,3 Anita Höcherl,2 Alessandro Jäger,2 Vladimir Sincari,2 Bo Nyström,4 Petr Štěpánek,2 Tore Skotland,5 Kirsten Sandvig,5,6 Martin Hrubý,2 Gunhild M Mælandsmo...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Pandya AD, Jäger E, Bagheri Fam S, Höcherl A, Jäger A, Sincari V, Nyström B, Štěpánek P, Skotland T, Sandvig K, Hrubý M, Mælandsmo GM
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2019
Materias:
Acceso en línea:https://doaj.org/article/ae5a20d5062441a4968f7b39df48feca
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:ae5a20d5062441a4968f7b39df48feca
record_format dspace
spelling oai:doaj.org-article:ae5a20d5062441a4968f7b39df48feca2021-12-02T10:40:50ZPaclitaxel-loaded biodegradable ROS-sensitive nanoparticles for cancer therapy1178-2013https://doaj.org/article/ae5a20d5062441a4968f7b39df48feca2019-08-01T00:00:00Zhttps://www.dovepress.com/paclitaxel-loaded-biodegradable-ros-sensitive-nanoparticles-for-cancer-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Abhilash D Pandya,1 Eliézer Jäger,2 Shahla Bagheri Fam,3 Anita Höcherl,2 Alessandro Jäger,2 Vladimir Sincari,2 Bo Nyström,4 Petr Štěpánek,2 Tore Skotland,5 Kirsten Sandvig,5,6 Martin Hrubý,2 Gunhild M Mælandsmo1,71Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway; 2Institute of Macromolecular Chemistry v.v.i, Academy of Sciences of the Czech Republic, Prague, Czech Republic; 3Department of Radiation Biology, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway; 4Department of Chemistry, University of Oslo, Oslo, Norway; 5Department of Molecular Cell Biology, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway; 6Department of Biosciences, University of Oslo, Oslo, Norway; 7Institute of Medical Biology, Faculty of Health Sciences, The Arctic University of Norway – University of Tromsø, Tromsø, NorwayBackground: Reactive oxygen species (ROS), such as hydrogen peroxide and superoxide, trigger biodegradation of polymer-based nanoparticles (NPs) bearing pinacol-type boronic ester groups. These NPs may selectively release their cargo, in this case paclitaxel (PTX), at the high levels of ROS present in the intracellular environment of inflamed tissues and most tumors.Purpose: The main objective was to determine anti-tumor efficacy of PTX-loaded ROS-sensitive NPs and to examine whether macrophage infiltration had any impact on treatment efficacy.Methods: NPs were synthesized and their characteristics in the presence of H2O2 were demonstrated. Both confocal microscopy as well as flow cytometry approaches were used to determine degradation of ROS-sensitive NPs. HeLa cells were cultured in vitro and used to establish tumor xenografts in nude mice. In vivo experiments were performed to understand toxicity, biodistribution and anti-tumor efficacy of the NPs. Moreover, we performed immunohistochemistry on tumor sections to study infiltration of M1 and M2 subsets of macrophages.Results: We demonstrated that PTX delivered in NPs containing a ROS-sensitive polymer exhibits a better anti-tumor efficacy than PTX in NPs containing ROS-non-sensitive polymer, free PTX or Abraxane® (nab-PTX). The biodistribution revealed that ROS-sensitive NPs exhibit retention in liver, spleen and lungs, suggesting a potential to target cancer metastasizing to these organs. Finally, we demonstrated a correlation between infiltrated macrophage subsets and treatment efficacy, possibly contributing to the efficient anti-tumor effects.Conclusion: Treatment with ROS-sensitive NPs containing PTX gave an improved therapeutic effect in HeLa xenografts than their counterpart, free PTX or nab-PTX. Our data revealed a correlation between macrophage infiltration and efficiency of the different antitumor treatments, as the most effective NPs resulted in the highest infiltration of the anti-tumorigenic M1 macrophages.Keywords: reactive oxygen species, ROS-sensitive nanoparticles, paclitaxel, treatment efficacy, macrophage infiltrationPandya ADJäger EBagheri Fam SHöcherl AJäger ASincari VNyström BŠtěpánek PSkotland TSandvig KHrubý MMælandsmo GMDove Medical PressarticleReactive oxygen speciesROS-sensitive nanoparticlesPaclitaxelTreatment efficacyMacrophage infiltrationMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 14, Pp 6269-6285 (2019)
institution DOAJ
collection DOAJ
language EN
topic Reactive oxygen species
ROS-sensitive nanoparticles
Paclitaxel
Treatment efficacy
Macrophage infiltration
Medicine (General)
R5-920
spellingShingle Reactive oxygen species
ROS-sensitive nanoparticles
Paclitaxel
Treatment efficacy
Macrophage infiltration
Medicine (General)
R5-920
Pandya AD
Jäger E
Bagheri Fam S
Höcherl A
Jäger A
Sincari V
Nyström B
Štěpánek P
Skotland T
Sandvig K
Hrubý M
Mælandsmo GM
Paclitaxel-loaded biodegradable ROS-sensitive nanoparticles for cancer therapy
description Abhilash D Pandya,1 Eliézer Jäger,2 Shahla Bagheri Fam,3 Anita Höcherl,2 Alessandro Jäger,2 Vladimir Sincari,2 Bo Nyström,4 Petr Štěpánek,2 Tore Skotland,5 Kirsten Sandvig,5,6 Martin Hrubý,2 Gunhild M Mælandsmo1,71Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway; 2Institute of Macromolecular Chemistry v.v.i, Academy of Sciences of the Czech Republic, Prague, Czech Republic; 3Department of Radiation Biology, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway; 4Department of Chemistry, University of Oslo, Oslo, Norway; 5Department of Molecular Cell Biology, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway; 6Department of Biosciences, University of Oslo, Oslo, Norway; 7Institute of Medical Biology, Faculty of Health Sciences, The Arctic University of Norway – University of Tromsø, Tromsø, NorwayBackground: Reactive oxygen species (ROS), such as hydrogen peroxide and superoxide, trigger biodegradation of polymer-based nanoparticles (NPs) bearing pinacol-type boronic ester groups. These NPs may selectively release their cargo, in this case paclitaxel (PTX), at the high levels of ROS present in the intracellular environment of inflamed tissues and most tumors.Purpose: The main objective was to determine anti-tumor efficacy of PTX-loaded ROS-sensitive NPs and to examine whether macrophage infiltration had any impact on treatment efficacy.Methods: NPs were synthesized and their characteristics in the presence of H2O2 were demonstrated. Both confocal microscopy as well as flow cytometry approaches were used to determine degradation of ROS-sensitive NPs. HeLa cells were cultured in vitro and used to establish tumor xenografts in nude mice. In vivo experiments were performed to understand toxicity, biodistribution and anti-tumor efficacy of the NPs. Moreover, we performed immunohistochemistry on tumor sections to study infiltration of M1 and M2 subsets of macrophages.Results: We demonstrated that PTX delivered in NPs containing a ROS-sensitive polymer exhibits a better anti-tumor efficacy than PTX in NPs containing ROS-non-sensitive polymer, free PTX or Abraxane® (nab-PTX). The biodistribution revealed that ROS-sensitive NPs exhibit retention in liver, spleen and lungs, suggesting a potential to target cancer metastasizing to these organs. Finally, we demonstrated a correlation between infiltrated macrophage subsets and treatment efficacy, possibly contributing to the efficient anti-tumor effects.Conclusion: Treatment with ROS-sensitive NPs containing PTX gave an improved therapeutic effect in HeLa xenografts than their counterpart, free PTX or nab-PTX. Our data revealed a correlation between macrophage infiltration and efficiency of the different antitumor treatments, as the most effective NPs resulted in the highest infiltration of the anti-tumorigenic M1 macrophages.Keywords: reactive oxygen species, ROS-sensitive nanoparticles, paclitaxel, treatment efficacy, macrophage infiltration
format article
author Pandya AD
Jäger E
Bagheri Fam S
Höcherl A
Jäger A
Sincari V
Nyström B
Štěpánek P
Skotland T
Sandvig K
Hrubý M
Mælandsmo GM
author_facet Pandya AD
Jäger E
Bagheri Fam S
Höcherl A
Jäger A
Sincari V
Nyström B
Štěpánek P
Skotland T
Sandvig K
Hrubý M
Mælandsmo GM
author_sort Pandya AD
title Paclitaxel-loaded biodegradable ROS-sensitive nanoparticles for cancer therapy
title_short Paclitaxel-loaded biodegradable ROS-sensitive nanoparticles for cancer therapy
title_full Paclitaxel-loaded biodegradable ROS-sensitive nanoparticles for cancer therapy
title_fullStr Paclitaxel-loaded biodegradable ROS-sensitive nanoparticles for cancer therapy
title_full_unstemmed Paclitaxel-loaded biodegradable ROS-sensitive nanoparticles for cancer therapy
title_sort paclitaxel-loaded biodegradable ros-sensitive nanoparticles for cancer therapy
publisher Dove Medical Press
publishDate 2019
url https://doaj.org/article/ae5a20d5062441a4968f7b39df48feca
work_keys_str_mv AT pandyaad paclitaxelloadedbiodegradablerossensitivenanoparticlesforcancertherapy
AT jagere paclitaxelloadedbiodegradablerossensitivenanoparticlesforcancertherapy
AT bagherifams paclitaxelloadedbiodegradablerossensitivenanoparticlesforcancertherapy
AT hocherla paclitaxelloadedbiodegradablerossensitivenanoparticlesforcancertherapy
AT jagera paclitaxelloadedbiodegradablerossensitivenanoparticlesforcancertherapy
AT sincariv paclitaxelloadedbiodegradablerossensitivenanoparticlesforcancertherapy
AT nystromb paclitaxelloadedbiodegradablerossensitivenanoparticlesforcancertherapy
AT stepanekp paclitaxelloadedbiodegradablerossensitivenanoparticlesforcancertherapy
AT skotlandt paclitaxelloadedbiodegradablerossensitivenanoparticlesforcancertherapy
AT sandvigk paclitaxelloadedbiodegradablerossensitivenanoparticlesforcancertherapy
AT hrubym paclitaxelloadedbiodegradablerossensitivenanoparticlesforcancertherapy
AT mælandsmogm paclitaxelloadedbiodegradablerossensitivenanoparticlesforcancertherapy
_version_ 1718396849140793344